J Korean Med Sci.  2022 Jul;37(26):e217. 10.3346/jkms.2022.37.e217.

Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome

• Finsterer J

• KMID: 2531041
• DOI: http://doi.org/10.3346/jkms.2022.37.e217

Reference

1. Kim JW, Kim YG, Park YC, Choi S, Lee S, Min HJ, et al. Guillain-barre syndrome after two COVID-19 vaccinations: two case reports with follow-up electrodiagnostic study. J Korean Med Sci. 2022; 37(7):e58. PMID: 35191234.

2. Leppert D, Waespe W. Neurotoxicity of antituberculous drugs in a patient without active tuberculosis. Ital J Neurol Sci. 1988; 9(1):29–34. PMID: 3170167.

3. Geyer HL, Herskovitz S, Slamovits TL, Schaumburg HH. Optochiasmatic and peripheral neuropathy due to ethambutol overtreatment. J Neuroophthalmol. 2014; 34(3):257–258. PMID: 24897009.

4. Stettner M, Steinberger D, Hartmann CJ, Pabst T, Konta L, Hartung HP, et al. Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping? Brain Behav. 2015; 5(8):e00326. PMID: 26355945.

5. Al-Rasbi S, Al-Maqbali JS, Al-Farsi R, Al Shukaili MA, Al-Riyami MH, Al Falahi Z, et al. Myocarditis, pulmonary hemorrhage, and extensive myositis with rhabdomyolysis 12 days after first dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: a case report. Am J Case Rep. 2022; 23:e934399. PMID: 35173141.